Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group

Arthritis Care & Research
Chayawee MuangchanJanet E Pope

Abstract

This study was performed to determine the prevalence of elevated C-reactive protein (CRP) levels and the significance of CRP in clinical parameters in systemic sclerosis (SSc; scleroderma) patients. Canadian Scleroderma Research Group data were used. Statistical comparisons were made for CRP levels ≤8 mg/liter versus >8 mg/liter, early (≤3 years from first non-Raynaud's phenomenon symptom) versus late SSc, and diffuse cutaneous SSc (dcSSc) versus limited cutaneous SSc (lcSSc). A survival analysis was analyzed between patients with normal versus elevated CRP levels. A total of 1,043 patients (mean ± SD age 55.4 ± 12.1 years, mean ± SD disease duration of 11.0 ± 9.5 years) were analyzed; elevation of CRP level and erythrocyte sedimentation rate (ESR; >20 mm/hour) occurred in 25.7% and 38.2%, respectively. Mean ± SD baseline CRP level in dcSSc (11.98 ± 25.41 mg/liter) was higher than in lcSSc (8.15 ± 16.09 mg/liter; P = 0.016). SSc patients with an early disease duration had a higher mean ± SD CRP level (12.89 ± 28.13 mg/liter) than those with a late disease duration (8.60 ± 17.06 mg/liter; P = 0.041). Although not consistent in all subsets, CRP was significantly associated (P < 0.01) with ESR, modified Rodnan skin score (MRSS), w...Continue Reading

References

Feb 1, 1990·The Biochemical Journal·P C HeinrichT Andus
Feb 1, 1988·Postgraduate Medical Journal·A J BarnettG O Littlejohn
Sep 1, 1993·Journal of Internal Medicine·L CzirjákG Szegedi
Mar 13, 1998·Annals of the Rheumatic Diseases·C P SimeonG Sampol
Aug 26, 1998·British Journal of Rheumatology·S JacobsenS Ullman
Jan 30, 1999·Annals of the Rheumatic Diseases·R HesselstrandA Akesson
Nov 18, 2000·Arthritis and Rheumatism·V D Steen, T A Medsger
Apr 20, 2001·Rheumatology·C NishijimaK Takehara
Oct 12, 2001·Immunologic Research·R F Mortensen
Jun 18, 2003·European Radiology·Marjolein DrentJohny A Verschakelen
Aug 2, 2003·Clinical and Experimental Rheumatology·G ValentiniD Veale
Apr 15, 2005·The New England Journal of Medicine·Steven Woloshin, Lisa M Schwartz
Nov 5, 2005·Circulation Research·Chieko MineoPhilip W Shaul
May 24, 2007·Annals of the Rheumatic Diseases·L CzirjákG Szucs
May 29, 2007·Arthritis and Rheumatism·Glenys A TennentMark B Pepys
Apr 12, 2008·Clinical Chemistry·Alyson Kelley-HedgepethUNKNOWN SWAN Investigators
Aug 19, 2008·Seminars in Arthritis and Rheumatism·Firas F Al-DhaherJanine M Ouimet
Jan 29, 2009·Rheumatology·Eric HachullaUNKNOWN ItinérAIR-Sclérodermie Study Investigators
Feb 3, 2009·The British Journal of Dermatology·C SunderkötterUNKNOWN DNSS Centers
Mar 12, 2009·Clinical Rheumatology·Paola Coral-AlvaradoJuan-Manuel Anaya
Apr 4, 2009·Journal of the American College of Cardiology·Rozenn QuarckMarion Delcroix
Dec 4, 2009·Clinical Rheumatology·Jinhyun KimEun Bong Lee
Jul 16, 2011·Clinica Chimica Acta; International Journal of Clinical Chemistry·Michael MahlerMarvin J Fritzler

❮ Previous
Next ❯

Citations

Sep 19, 2012·International Journal of Rheumatology·Harpreet K Lota, Elisabetta A Renzoni
Dec 19, 2013·Rheumatology International·Lech ChrostekStanislaw Sierakowski
Sep 3, 2014·La Presse médicale·Veronika LórándTünde Minier
Jun 18, 2014·Molecular Diagnosis & Therapy·Angelo De Lauretis, Elisabetta A Renzoni
Jul 7, 2015·Expert Review of Respiratory Medicine·Ilaria CampoFrancesco Bonella
Oct 31, 2013·Expert Review of Clinical Immunology·Flavia V Castelino, John Varga
Nov 13, 2015·Expert Review of Clinical Immunology·Mike O Becker, Gabriela Riemekasten
Nov 5, 2016·Expert Opinion on Orphan Drugs·Fabian A MendozaSergio A Jimenez
Oct 14, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·R ChandirasekarK Sasikala
Dec 22, 2015·Immunologic Research·Aniko RentkaAdam Kemeny-Beke
Sep 17, 2015·Orthopedics·Andy TanaghoSameh Ansara
Apr 25, 2014·The American Journal of Medicine·Tomoyuki Kawada
Mar 13, 2015·Current Rheumatology Reports·Ivan Foeldvari
Oct 25, 2016·Arthritis Research & Therapy·James EspositoMandana Nikpour
Jun 24, 2017·European Journal of Clinical Investigation·Marzena CiechomskaKatarzyna Bogunia-Kubik
Dec 1, 2017·Rheumatology International·Philippa AshmoreClaudia Ickinger
Mar 8, 2018·The Journal of International Medical Research·Anna Lis-ŚwiętyEugeniusz Kucharz
Dec 17, 2017·Arthritis Research & Therapy·Sébastien SangesDavid Launay
Feb 19, 2013·The Journal of Rheumatology·Samah MansourUNKNOWN Canadian Scleroderma Research Group
Nov 21, 2018·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Anne Sofie SiebuhrJuan C Chavez
May 6, 2016·Current Rheumatology Reports·Jessica K Gordon, Robyn T Domsic
Jul 6, 2016·Current Opinion in Rheumatology·Mirko Manetti
Dec 13, 2016·International Journal of Rheumatic Diseases·Alejandro Fernández MoralesGerard Espinosa
Aug 23, 2019·Current Opinion in Rheumatology·Brian Skaug, Shervin Assassi
Oct 28, 2020·Journal of Clinical Medicine·Akira UtsunomiyaMinoru Hasegawa
Feb 11, 2021·Modern Rheumatology·Chawiporn MuktabhantChingching Foocharoen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.